22-50447194-G-A
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2
The NM_002972.4(SBF1):c.5630C>T(p.Pro1877Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00101 in 1,613,734 control chromosomes in the GnomAD database, including 7 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_002972.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SBF1 | NM_002972.4 | c.5630C>T | p.Pro1877Leu | missense_variant | 41/41 | ENST00000380817.8 | NP_002963.2 | |
SBF1 | NM_001410794.1 | c.5633C>T | p.Pro1878Leu | missense_variant | 41/41 | NP_001397723.1 | ||
SBF1 | NM_001365819.1 | c.5555C>T | p.Pro1852Leu | missense_variant | 40/40 | NP_001352748.1 | ||
SBF1 | NM_001410795.1 | c.5552C>T | p.Pro1851Leu | missense_variant | 40/40 | NP_001397724.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SBF1 | ENST00000380817.8 | c.5630C>T | p.Pro1877Leu | missense_variant | 41/41 | 1 | NM_002972.4 | ENSP00000370196.2 |
Frequencies
GnomAD3 genomes AF: 0.000854 AC: 130AN: 152238Hom.: 1 Cov.: 33
GnomAD3 exomes AF: 0.000951 AC: 236AN: 248086Hom.: 1 AF XY: 0.00113 AC XY: 152AN XY: 134998
GnomAD4 exome AF: 0.00102 AC: 1492AN: 1461378Hom.: 6 Cov.: 32 AF XY: 0.00109 AC XY: 789AN XY: 727010
GnomAD4 genome AF: 0.000853 AC: 130AN: 152356Hom.: 1 Cov.: 33 AF XY: 0.000967 AC XY: 72AN XY: 74492
ClinVar
Submissions by phenotype
not provided Benign:4
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Mar 16, 2020 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 27, 2024 | - - |
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Jan 01, 2024 | SBF1: BS2 - |
SBF1-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | May 26, 2021 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at